Due to the number of contributing authors, the affiliations are provided in the Supplemental Material .
Clin J Am Soc Nephrol. 2018 Apr 6;13(4):612-619. doi: 10.2215/CJN.12171017. Epub 2018 Feb 22.
Kidney stones are associated with future development of hypertension, diabetes, and the metabolic syndrome. Our objective was to assess whether stone formation before pregnancy was associated with metabolic and hypertensive complications in pregnancy. We hypothesized that stone formation is a marker of metabolic disease and would be associated with higher risk for maternal complications in pregnancy.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a retrospective cohort study of women who delivered infants at the Massachusetts General Hospital from 2006 to 2015. Women with abdominal imaging (computed tomography or ultrasound) before pregnancy were included in the analysis. Pregnancy outcomes in women with documented kidney stones on imaging (stone formers, =166) were compared with those of women without stones on imaging (controls, =1264). Women with preexisting CKD, hypertension, and diabetes were excluded.
Gestational diabetes and preeclampsia were more common in stone formers than nonstone formers (18% versus 6%, respectively; <0.001 and 16% versus 8%, respectively; =0.002). After multivariable adjustment, previous nephrolithiasis was associated with higher risks of gestational diabetes (adjusted odds ratio, 3.1; 95% confidence interval, 1.8 to 5.3) and preeclampsia (adjusted odds ratio, 2.2; 95% confidence interval, 1.3 to 3.6). Infants of stone formers were born earlier (38.7±2.0 versus 39.2±1.7 weeks, respectively; =0.01); however, rates of small for gestational age offspring and neonatal intensive care admission were similar between groups (8% versus 7%, respectively; =0.33 and 10% versus 6%, respectively; =0.08). First trimester body mass index significantly influenced the association between stone disease and hypertensive complications of pregnancy: in a multivariable linear regression model, stone formation acted as an effect modifier of the relationship between maximum systolic BP in the third trimester and body mass index ( interaction <0.001).
In women without preexisting diabetes, hypertension, and CKD, a history of nephrolithiasis was associated with gestational diabetes and hypertensive disorders of pregnancy, especially in women with high first trimester body mass index.
肾结石与未来高血压、糖尿病和代谢综合征的发展有关。我们的目的是评估妊娠前结石形成是否与妊娠期间的代谢和高血压并发症有关。我们假设结石形成是代谢疾病的标志物,与妊娠期间母亲并发症的风险增加有关。
设计、地点、参与者和测量方法:我们对 2006 年至 2015 年在马萨诸塞州综合医院分娩的妇女进行了回顾性队列研究。将有妊娠前腹部影像学(计算机断层扫描或超声)的妇女纳入分析。与影像学无结石的妇女(对照组,n=1264)相比,影像学有肾结石记录的妇女(结石形成者,n=166)的妊娠结局。排除了有预先存在的 CKD、高血压和糖尿病的妇女。
与非结石形成者相比,结石形成者的妊娠糖尿病和子痫前期更为常见(分别为 18%和 16%,均<0.001;分别为 8%和 10%,均=0.002)。经多变量调整后,既往肾结石与妊娠糖尿病(调整后的优势比,3.1;95%置信区间,1.8 至 5.3)和子痫前期(调整后的优势比,2.2;95%置信区间,1.3 至 3.6)的风险增加相关。结石形成者的婴儿出生更早(分别为 38.7±2.0 和 39.2±1.7 周,分别;=0.01);然而,两组的小于胎龄儿和新生儿重症监护入院率相似(分别为 8%和 7%,分别;=0.33 和 10%和 6%,分别;=0.08)。妊娠早期的体重指数显著影响结石疾病与妊娠高血压并发症之间的关联:在多变量线性回归模型中,结石形成是妊娠晚期最大收缩压与体重指数之间关系的效应修饰因子(交互作用<0.001)。
在没有预先存在的糖尿病、高血压和 CKD 的妇女中,肾结石病史与妊娠糖尿病和妊娠高血压疾病有关,尤其是在妊娠早期体重指数高的妇女中。